Marvin Martens, MSc (M.T.L.J.)
Key publicaties
-
Martens, M. T. L. J. (2024). Adverse outcome pathways coming to life: exploring new ways to support risk assessments. [Doctoral Thesis, Maastricht University]. Maastricht University. https://doi.org/10.26481/dis.20240129mmMeer informative over deze publicatie
-
Martens, M., Verbruggen, T., Nymark, P., Grafstrom, R., Burgoon, L. D., Aladjov, H., Andon, F. T., Evelo, C. T., & Willighagen, E. L. (2018). Introducing WikiPathways as a Data-Source to Support Adverse Outcome Pathways for Regulatory Risk Assessment of Chemicals and Nanomaterials. Frontiers in Genetics, 9, Article 661. https://doi.org/10.3389/fgene.2018.00661Meer informative over deze publicatie
-
Martens, M., Ammar, A., Riutta, A., Waagmeester, A., Slenter, D., Hanspers, K., Miller, R., Digles, D., Lopes, E. N., Ehrhart, F., Dupuis, L. J., Winckers, L. A., Coort, S. L., Willighagen, E. L., Evelo, C. T., Pico, A. R., & Kutmon, M. (2021). WikiPathways: connecting communities. Nucleic Acids Research, 49(D1), D613-D621. https://doi.org/10.1093/nar/gkaa1024Meer informative over deze publicatie
-
Martens, M., Evelo, C. T., & Willighagen, E. L. (2022). Providing Adverse Outcome Pathways from the AOP-Wiki in a Semantic Web Format to Increase Usability and Accessibility of the Content. Applied in Vitro Toxicology, 8(1), 2-13. https://doi.org/10.1089/aivt.2021.0010Meer informative over deze publicatie
-
Mortensen, H. M., Martens, M., Senn, J., Levey, T., Evelo, C. T., Willighagen, E. L., & Exner, T. (2022). The AOP-DB RDF: Applying FAIR Principles to the Semantic Integration of AOP Data Using the Research Description Framework. Frontiers in Toxicology, 4, Article 803983. https://doi.org/10.3389/ftox.2022.803983Meer informative over deze publicatie
-
Murugadoss, S., Vrcek, I. V., Pem, B., Jagiello, K., Judzinska, B., Sosnowska, A., Martens, M., Willighagen, E. L., Puzyn, T., Dusinska, M., Cimpan, M. R., Fessard, V., & Hoet, P. H. (2021). A Strategy Towards the Generation of Testable Adverse Outcome Pathways for Nanomaterials. Altex-Alternatives To Animal Experimentation, 38(4), 580-594. https://doi.org/10.14573/altex.2102191Meer informative over deze publicatie
-
Kyzer, J. L., & Martens, M. (2021). Metabolism and Toxicity of Fluorine Compounds. Chemical Research in Toxicology, 34(3), 678-680. https://doi.org/10.1021/acs.chemrestox.0c00439Meer informative over deze publicatie
-
Martens, M., Stierum, R., Schymanski, E. L., Evelo, C. T., Aalizadeh, R., Aladjov, H., Arturi, K., Audouze, K., Babica, P., Berka, K., Bessems, J., Blaha, L., Bolton, E. E., Cases, M., Damalas, D. ., Dave, K., Dilger, M., Exner, T., Geerke, D. P., ... Et al. (2023). ELIXIR and Toxicology: a community in development. F1000Research, 10(1), Article 1129. https://doi.org/10.12688/f1000research.74502.2Meer informative over deze publicatie
-
Murugadoss, S., Vinkovic Vrcek, I., Schaffert, A., Paparella, M., Pem, B., Sosnowska, A., Stepnik, M., Martens, M., Willighagen, E. L., Puzyn, T., Roxana Cimpan, M., Lemaire, F., Mertens, B., Dusinska, M., Fessard, V., & Hoet, P. H. (2024). Linking nanomaterial-induced mitochondrial dysfunction to existing adverse outcome pathways for chemicals. ALTEX, 41(1), 76-90. https://doi.org/10.14573/altex.2305011Meer informative over deze publicatie
-
Anfray, C., Mainini, F., Digifico, E., Maeda, A., Sironi, M., Erreni, M., Anselmo, A., Ummarino, A., Gandoy, S., Exposito, F., Redrado, M., Serrano, D., Calvo, A., Martens, M., Bravo, S., Mantovani, A., Allavena, P., & Andon, F. T. (2021). Intratumoral combination therapy with poly(I:C) and resiquimod synergistically triggers tumor-associated macrophages for effective systemic antitumoral immunity. Journal for ImmunoTherapy of Cancer, 9(9), Article e002408. https://doi.org/10.1136/jitc-2021-002408Meer informative over deze publicatie